Lenz & Staehelin advised Asceneuron in its Series C financing.Asceneuron SA, a clinical stage biotech company developing small molecules targeting tau protein aggregation, a root cause…
Asceneuron SA’s $100 Million Series C Financing Round
Lenz & Staehelin advised Asceneuron in its Series C financing.Asceneuron SA, a clinical stage biotech company developing small molecules targeting tau protein aggregation, a root cause…